Louise Wilkie | executive |
Alexander Macrae | executive |
James Stamos | analyst |
Amy Pooler | executive |
Huidong Wang | analyst |
Nathalie Dubois-Stringfellow | executive |
Luis Santos | analyst |
Lisa Walter | analyst |
Ritu Baral | analyst |
Good day, and welcome to the Sangamo Therapeutics First Quarter 2024 Teleconference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to turn the conference over to your speaker today, Louise Wilkie, Vice President of Investor Relations and Corporate Communications. Please go ahead.
Thank you.